EU Pharma Strategy Archives - Action Santé Mondiale

We believe in alternative funding and pricing models that can encourage pharmaceutical companies to innovate and to charge reasonable prices

Blog series

Promoting transparent and needs-driven EU R&D policies

We believe in alternative funding and pricing models that can encourage pharmaceutical companies to innovate and to charge reasonable prices

By Ella Weggen, Global health advocate at Wemos

actionsantemondiale28 September 2022

It is clear that transparency creates trust, and that the Political institutions should be irreproachable in that regard

Blog series

Promoting transparent and needs-driven EU R&D policies

It is clear that transparency creates trust, and that the Political institutions should be irreproachable in that regard

By Tilly Metz, Member of the EU Parliament

actionsantemondiale28 September 2022

Transparency is key to unlocking better policies

Blog series

Transparency is key to unlocking better policies

By Ellen T'Hoen, lawyer and director of Medicine Law & Policy

actionsantemondiale28 September 2022

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.